Bath & Body Works Hits 52-Week Low at $23.79 Amid Declining Performance

Bath & Body Works, Inc. has reached a new 52-week low, trading at USD 23.79 as of October 30, 2025. This marks a significant decline for the small-cap company, which operates within the footwear industry. Over the past year, Bath & Body Works has experienced a notable drop in performance, with a decrease of 47.56%, contrasting sharply with the S&P 500's gain of 18.13% during the same period.
The company's financial metrics reveal a challenging landscape. With a market capitalization of USD 6,299 million, Bath & Body Works has a price-to-earnings (P/E) ratio of 7.00, indicating a low valuation relative to earnings. However, the company faces hurdles with a negative book value and a return on equity that is significantly low. Additionally, net sales have contracted at an annual rate of 8.28%, while operating profit has shown minimal growth.

The stock's performance has been characterized by consistent underperformance against the S&P 500 over the last three years, raising concerns about its long-term fundamental strength. As Bath & Body Works navigates these financial challenges, its recent price movement reflects the ongoing volatility in its market position.